Streetbeat News

Price Targets

UBX

Wedbush analyst Andreas Argyrides upgraded Unity Biotechnology Inc (NASDAQ:UBX) from Neutral to Outperform and raised the price target from $2 to $4. The upgrade reflects Unity's strong cash position and successful execution, particularly after positive results from the Ph2 BEHOLD trial for UBX1325/DME. The company plans to initiate a Ph2b trial against aflibercept in patients with DME later in 2023 and report further trial results in Q4:24 and Q1:25. Unity ended Q3 with $45.9 million in cash, providing a runway into Q2:25. UBX shares dropped by 1.09% to $1.81.

Portfolio Pulse from Shivani Kumaresan

November 16, 2023 | 7:41 pm

PSN

Jefferies analyst Sheila Kahyaoglu has maintained a Buy rating on Parsons Corp (NYSE:PSN) and increased the price target from $75 to $80.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 7:35 pm

TGT

Roth MKM analyst Bill Kirk has reiterated a Neutral rating on Target Corporation (NYSE:TGT) and maintained a price target of $140 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 7:22 pm

PANW

B of A Securities analyst Tal Liani has downgraded Palo Alto Networks (NASDAQ:PANW) from Buy to Neutral and reduced the price target from $290 to $265.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 7:17 pm

PANW

Following Palo Alto Networks Inc's (NASDAQ:PANW) Q3 FY23 results, several analysts have raised their price targets due to better-than-expected earnings and revenue. The company reported an EPS of $1.38, surpassing the consensus estimate of $1.16, and revenue of $1.88 billion, beating the $1.84 billion estimate. Full-year 2024 earnings and revenue forecasts were also provided, with earnings expected to be between $5.40 and $5.53 per share, and revenue between $8.15 billion and $8.20 billion. Analysts from Needham, Oppenheimer, Stifel, Mizuho Securities, Goldman Sachs, Morgan Stanley, and Raymond James have reiterated their positive ratings and raised their price targets, citing factors such as solid revenue growth, trusted platform status, and strong cloud assets. Despite the positive outlook, PANW shares were trading lower by 5.85% at $241.37.

Portfolio Pulse from Lekha Gupta

November 16, 2023 | 7:12 pm

TTEK

Baird analyst Andrew Wittmann has maintained a Neutral rating on Tetra Tech (NASDAQ:TTEK) and increased the price target from $172 to $180.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 7:03 pm

LVS

Over the past 3 months, 4 Wall Street analysts have provided ratings for Las Vegas Sands (NYSE:LVS), with 2 bullish and 2 somewhat bullish ratings. The average price target is $69.75, representing an implied upside from the current price of $49.25. The target has increased by 0.36% over the past month. Analysts' ratings are based on research and provide guidance to investors, though they reflect opinions and can vary each quarter.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 7:00 pm

USB

U.S. Bancorp (NYSE:USB) has received 8 analyst ratings in the last quarter, with 3 somewhat bullish and 5 indifferent, and no bearish ratings. The average 12-month price target for USB is $47.5, representing a 6.61% decrease from the previous target of $50.86. Analysts consider factors such as future earnings, revenue streams, and company updates to provide these ratings.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 7:00 pm

JACK

Jack In The Box (NASDAQ:JACK) has received mostly indifferent analyst ratings in the last quarter, with 6 out of 7 ratings being neutral. The average 12-month price target among 7 analysts is $80.29, with a high of $101.00 and a low of $70.00. This target has decreased by 15.26% from the previous average of $94.75. Analysts typically review stocks quarterly or after major company updates, considering factors like future earnings and revenue predictability.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 7:00 pm

IMXUSD

Immutable's cryptocurrency, IMX, has seen a 6.07% decrease in price over the last 24 hours, now at $1.14, despite a 36% increase over the past week. The trading volume has decreased by 14%, while the circulating supply has risen by 0.35% to 1.25 billion coins. IMX's market cap is currently ranked #44 at $1.42 billion.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 7:00 pm